Crutcher K - Search Results

1

Live discussion: how the other half lives - or the what, how, and where, of the AbetaPP intracellular domain.

Bishop G, Coleman P, Crutcher K, David D, Kinoshita J, LaFerla F, Leissring M, Shepherd J, Therianos S, Wang R, Wilson A, Zhu M. Bishop G, et al. Among authors: crutcher k. J Alzheimers Dis. 2004 Apr;6(2):193-9. doi: 10.3233/jad-2004-6212. J Alzheimers Dis. 2004. PMID: 15171221 No abstract available.

2

Live discussion. From here to there: AbetaPP as an axonal transport receptor--how could this explain neurodegeneration in AD. 15 July 2002.

Goldstein L, Ashford JW, Busciglio J, Crutcher K, Gouras G, Kinoshita J, Mandelkow E, Sudol M. Goldstein L, et al. Among authors: crutcher k. J Alzheimers Dis. 2003 Dec;5(6):483-9. J Alzheimers Dis. 2003. PMID: 14765517 No abstract available.

3

Live discussion: Amyloid-beta degradation: the forgotten half of Alzheimer's disease. 12 September 2002.

Whitaker C, Eckman C, Almeida C, Feinstein D, Atwood C, Eckman E, Crutcher K, Hersh L, Leissring M, LaVoie M, Ertekin-Taner N, Shapiro P, Takahashi R, Yamin R, Mansourian S, Estus S, Lesné S, Turner T, Farris W, Stroebel G. Whitaker C, et al. Among authors: crutcher k. J Alzheimers Dis. 2003 Dec;5(6):491-7. J Alzheimers Dis. 2003. PMID: 14765518 No abstract available.

4

The presence of apoE4, not the absence of apoE3, contributes to AD pathology.

Teter B, Raber J, Nathan B, Crutcher KA. Teter B, et al. J Alzheimers Dis. 2002 Jun;4(3):155-63. doi: 10.3233/jad-2002-4305. J Alzheimers Dis. 2002. PMID: 12226534 Review. No abstract available.

5

Cellular and molecular pathology in Alzheimer's disease.

Crutcher KA, Anderton BH, Barger SW, Ohm TG, Snow AD. Crutcher KA, et al. Hippocampus. 1993;3 Spec No:271-87. Hippocampus. 1993. PMID: 8287105 Review. No abstract available.

6

Apolipoprotein E-related neurotoxicity as a therapeutic target for Alzheimer's disease.

Marques MA, Crutcher KA. Marques MA, et al. J Mol Neurosci. 2003;20(3):327-37. doi: 10.1385/JMN:20:3:327. J Mol Neurosci. 2003. PMID: 14501016

7

Nerve growth factor and Alzheimer's disease.

Scott SA, Crutcher KA. Scott SA, et al. Among authors: crutcher ka. Rev Neurosci. 1994 Jul-Sep;5(3):179-211. doi: 10.1515/revneuro.1994.5.3.179. Rev Neurosci. 1994. PMID: 7889213 Review.

8

Detection of NGF-like activity in human brain tissue: increased levels in Alzheimer's disease.

Crutcher KA, Scott SA, Liang S, Everson WV, Weingartner J. Crutcher KA, et al. J Neurosci. 1993 Jun;13(6):2540-50. doi: 10.1523/JNEUROSCI.13-06-02540.1993. J Neurosci. 1993. PMID: 8501520 Free PMC article.

9

Sympathetic neurite outgrowth is greater on plaque-poor vs. plaque-rich regions of Alzheimer's disease cryostat sections.

Tolar M, Scott SA, Crutcher KA. Tolar M, et al. Among authors: crutcher ka. Brain Res. 1998 Mar 16;787(1):49-58. doi: 10.1016/s0006-8993(97)01455-8. Brain Res. 1998. PMID: 9518548

10

Nerve growth factor in Alzheimer's disease: increased levels throughout the brain coupled with declines in nucleus basalis.

Scott SA, Mufson EJ, Weingartner JA, Skau KA, Crutcher KA. Scott SA, et al. Among authors: crutcher ka. J Neurosci. 1995 Sep;15(9):6213-21. doi: 10.1523/JNEUROSCI.15-09-06213.1995. J Neurosci. 1995. PMID: 7666203 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

124 results

Search Page

Filters